Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences informs about press release
Date: 25-11-2025Zydus Lifesciences has informed that it enclosed a copy of press release dated November 25, 2025, titled ‘Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg’.
The above information is a part of company’s filings submitted to BSE.